BioAro Inc
$5,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2026-2027
- Agreement period
- April 1, 2026 – May 20, 2026
- Reference
- nrc-cnrc:172-2026-2027-Q1-1042343
Published purpose
Participation in the Canadian medical biotechnology co-innovation mission to the Eureka Global Innovation Summit and Swiss Biotech Day in Switzerland – May 3 to 8, 2026. Through this mission, BioAro proposes to showcase its technologies to the Swiss Pharma market specifically focusing on the use of PanOmiQ & Genolio for drug discovery and repurposing of existing drugs besides identifying novel targets, thrugh a multi-OMICS approach. The following sectors are being targeted through this mission, for collaborations and identification of partners for Eureka submissions:
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 10, 2026 from open.canada.ca Grants & Contributions